(2026). Targeting the miR‐224‐5p/PTEN pathway: A previously under‐characterized strategy to attenuate mesangial cell injury and predict prognosis in diabetic nephropathy. Journal of Diabetes Investigation.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Targeting the MiR‐224‐5p/PTEN Pathway: A Previously Under‐characterized Strategy to Attenuate Mesangial Cell Injury and Predict Prognosis in Diabetic Nephropathy."
Journal of Diabetes Investigation 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Targeting the MiR‐224‐5p/PTEN Pathway: A Previously Under‐characterized Strategy to Attenuate Mesangial Cell Injury and Predict Prognosis in Diabetic Nephropathy."
Journal of Diabetes Investigation, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.